APO Research
Talk to an analyst

APO RESEARCH · REPORT

Metformin Drugs

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Metformin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

2 January 2026191 pages

Choose your research edition.

Industry ResearchMetformin Drugs Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Metformin Drugs Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Metformin Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Metformin Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Metformin Drugs Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Metformin Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Metformin Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Metformin Drugs include Alkem, Apotex, Atlas Pharmaceuticals, Bristol-Myers Squibb, Dr. Reddy’s Laboratories, Mallinckrodt, Teva Pharmaceuticals, Torrent Pharmaceuticals and Viatris, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Metformin Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Metformin Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Metformin Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Metformin Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Metformin Drugs Segment by Company

Alkem

Apotex

Atlas Pharmaceuticals

Bristol-Myers Squibb

Dr. Reddy’s Laboratories

Mallinckrodt

Teva Pharmaceuticals

Torrent Pharmaceuticals

Viatris

Novartis

Sun Pharmaceutical Industries

Metformin Drugs Segment by Type

50 Tablets

100 Tablets

Other

Metformin Drugs Segment by Application

Hospital

Drugs Stores

Metformin Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Metformin Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Metformin Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Metformin Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Metformin Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Metformin Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Metformin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Metformin Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Metformin Drugs Industry Trends Table 2. Metformin Drugs Industry Drivers Table 3. Metformin Drugs Industry Opportunities and Challenges Table 4. Metformin Drugs Industry Restraints Table 5. Global Metformin Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Metformin Drugs Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Metformin Drugs Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Metformin Drugs Sales Market Share by Manufacturers Table 9. Global Metformin Drugs Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Metformin Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Metformin Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Metformin Drugs Manufacturers, Product Type & Application Table 13. Global Metformin Drugs Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Metformin Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 50 Tablets Table 17. Major Manufacturers of 100 Tablets Table 18. Major Manufacturers of Other Table 19. Global Metformin Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Metformin Drugs Sales by Type (2021-2026) & (K Units) Table 21. Global Metformin Drugs Sales by Type (2027-2032) & (K Units) Table 22. Global Metformin Drugs Sales Market Share by Type (2021-2026) Table 23. Global Metformin Drugs Sales Market Share by Type (2027-2032) Table 24. Global Metformin Drugs Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 25. Global Metformin Drugs Revenue by Type (2021-2026) & (K Units) Table 26. Global Metformin Drugs Revenue by Type (2027-2032) & (K Units) Table 27. Global Metformin Drugs Revenue Market Share by Type (2021-2026) Table 28. Global Metformin Drugs Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Hospital Table 30. Major Manufacturers of Drugs Stores Table 31. Global Metformin Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 32. Global Metformin Drugs Sales by Application (2021-2026) & (K Units) Table 33. Global Metformin Drugs Sales by Application (2027-2032) & (K Units) Table 34. Global Metformin Drugs Sales Market Share by Application (2021-2026) Table 35. Global Metformin Drugs Sales Market Share by Application (2027-2032) Table 36. Global Metformin Drugs Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 37. Global Metformin Drugs Revenue by Application (2021-2026) & (K Units) Table 38. Global Metformin Drugs Revenue by Application (2027-2032) & (K Units) Table 39. Global Metformin Drugs Revenue Market Share by Application (2021-2026) Table 40. Global Metformin Drugs Revenue Market Share by Application (2027-2032) Table 41. Global Metformin Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 42. Global Metformin Drugs Sales by Region (2021-2026) & (K Units) Table 43. Global Metformin Drugs Sales Market Share by Region (2021-2026) Table 44. Global Metformin Drugs Sales Forecasted by Region (2027-2032) & (K Units) Table 45. Global Metformin Drugs Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 47. North America Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 48. North America Metformin Drugs Sales by Country (2027-2032) & (K Units) Table 49. Europe Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 50. Europe Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 51. Europe Metformin Drugs Sales by Country (2027-2032) & (K Units) Table 52. Asia Pacific Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 53. Asia Pacific Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 54. Asia Pacific Metformin Drugs Sales by Country (2027-2032) & (K Units) Table 55. South America, Middle East and Africa Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 56. South America, Middle East and Africa Metformin Drugs Sales by Country (2021-2026) & (K Units) Table 57. South America, Middle East and Africa Metformin Drugs Sales by Country (2027-2032) & (K Units) Table 58. Global Metformin Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Metformin Drugs Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Metformin Drugs Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Metformin Drugs Revenue Market Share by Region (2021-2026) Table 62. Global Metformin Drugs Revenue Market Share by Region (2027-2032) Table 63. Alkem Company Information Table 64. Alkem Business Overview Table 65. Alkem Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Alkem Metformin Drugs Product Portfolio Table 67. Alkem Recent Development Table 68. Apotex Company Information Table 69. Apotex Business Overview Table 70. Apotex Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Apotex Metformin Drugs Product Portfolio Table 72. Apotex Recent Development Table 73. Atlas Pharmaceuticals Company Information Table 74. Atlas Pharmaceuticals Business Overview Table 75. Atlas Pharmaceuticals Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Atlas Pharmaceuticals Metformin Drugs Product Portfolio Table 77. Atlas Pharmaceuticals Recent Development Table 78. Bristol-Myers Squibb Company Information Table 79. Bristol-Myers Squibb Business Overview Table 80. Bristol-Myers Squibb Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Bristol-Myers Squibb Metformin Drugs Product Portfolio Table 82. Bristol-Myers Squibb Recent Development Table 83. Dr. Reddy’s Laboratories Company Information Table 84. Dr. Reddy’s Laboratories Business Overview Table 85. Dr. Reddy’s Laboratories Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio Table 87. Dr. Reddy’s Laboratories Recent Development Table 88. Mallinckrodt Company Information Table 89. Mallinckrodt Business Overview Table 90. Mallinckrodt Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Mallinckrodt Metformin Drugs Product Portfolio Table 92. Mallinckrodt Recent Development Table 93. Teva Pharmaceuticals Company Information Table 94. Teva Pharmaceuticals Business Overview Table 95. Teva Pharmaceuticals Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Teva Pharmaceuticals Metformin Drugs Product Portfolio Table 97. Teva Pharmaceuticals Recent Development Table 98. Torrent Pharmaceuticals Company Information Table 99. Torrent Pharmaceuticals Business Overview Table 100. Torrent Pharmaceuticals Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Torrent Pharmaceuticals Metformin Drugs Product Portfolio Table 102. Torrent Pharmaceuticals Recent Development Table 103. Viatris Company Information Table 104. Viatris Business Overview Table 105. Viatris Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Viatris Metformin Drugs Product Portfolio Table 107. Viatris Recent Development Table 108. Novartis Company Information Table 109. Novartis Business Overview Table 110. Novartis Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Novartis Metformin Drugs Product Portfolio Table 112. Novartis Recent Development Table 113. Sun Pharmaceutical Industries Company Information Table 114. Sun Pharmaceutical Industries Business Overview Table 115. Sun Pharmaceutical Industries Metformin Drugs Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Sun Pharmaceutical Industries Metformin Drugs Product Portfolio Table 117. Sun Pharmaceutical Industries Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Metformin Drugs Distributors List Table 121. Metformin Drugs Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Metformin Drugs Product Image Figure 2. Global Metformin Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Metformin Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Metformin Drugs Sales (2021-2032) & (K Units) Figure 5. Global Metformin Drugs Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Metformin Drugs Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 50 Tablets Image Figure 9. 100 Tablets Image Figure 10. Other Image Figure 11. Global Metformin Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Metformin Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Metformin Drugs Sales Market Share by Type (2021-2032) Figure 14. Global Metformin Drugs Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Metformin Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Metformin Drugs Revenue Market Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drugs Stores Image Figure 19. Global Metformin Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 20. Global Metformin Drugs Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Metformin Drugs Sales Market Share by Application (2021-2032) Figure 22. Global Metformin Drugs Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 23. Global Metformin Drugs Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Metformin Drugs Revenue Market Share by Application (2021-2032) Figure 25. North America Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 26. North America Metformin Drugs Sales Market Share by Country (2021-2032) Figure 27. U.S. Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 28. Canada Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 29. Mexico Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 30. Europe Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 31. Europe Metformin Drugs Sales Market Share by Country (2021-2032) Figure 32. Germany Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 33. France Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 34. U.K. Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Italy Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Netherlands Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Asia Pacific Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Asia Pacific Metformin Drugs Sales Market Share by Country (2021-2032) Figure 39. China Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 40. Japan Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 41. South Korea Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Southeast Asia Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 43. India Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Australia Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 45. South America, Middle East and Africa Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 46. South America, Middle East and Africa Metformin Drugs Sales Market Share by Country (2021-2032) Figure 47. Brazil Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Africa Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Saudi Arabia Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 50. Turkey Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Argentina Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 52. UAE Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 53. Egypt Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 54. Chile Metformin Drugs Sales and Growth Rate (2021-2032) & (K Units) Figure 55. Global Metformin Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Metformin Drugs Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Metformin Drugs Revenue (2021-2032) & (US$ Million) Figure 58. North America Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Metformin Drugs Revenue (2021-2032) & (US$ Million) Figure 60. Europe Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Metformin Drugs Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Metformin Drugs Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Metformin Drugs Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Metformin Drugs Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • 50 Tablets
  • 100 Tablets
  • Other
Applications
  • Hospital
  • Drugs Stores
Companies covered
  • Alkem
  • Apotex
  • Atlas Pharmaceuticals
  • Bristol-Myers Squibb
  • Dr. Reddy’s Laboratories
  • Mallinckrodt
  • Teva Pharmaceuticals
  • Torrent Pharmaceuticals
  • Viatris
  • Novartis
  • Sun Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Metformin Drugs Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Metformin Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Metformin Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Metformin Drugs Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Metformin Drugs Market Dynamics
  1. 2.1 Metformin Drugs Industry Trends
  2. 2.2 Metformin Drugs Industry Drivers
  3. 2.3 Metformin Drugs Industry Opportunities and Challenges
  4. 2.4 Metformin Drugs Industry Restraints
3 Metformin Drugs Market by Manufacturers
  1. 3.1 Global Metformin Drugs Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Metformin Drugs Sales by Manufacturers (2021-2026)
  3. 3.3 Global Metformin Drugs Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Metformin Drugs Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Metformin Drugs Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Metformin Drugs Manufacturers, Product Type & Application
  7. 3.7 Global Metformin Drugs Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Metformin Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Metformin Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Metformin Drugs Tier 1, Tier 2, and Tier 3
4 Metformin Drugs Market by Type
  1. 4.1 Metformin Drugs Type Introduction
  2. 4.1.1 50 Tablets
  3. 4.1.2 100 Tablets
  4. 4.1.3 Other
  5. 4.2 Global Metformin Drugs Sales by Type
  6. 4.2.1 Global Metformin Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Metformin Drugs Sales by Type (2021-2032)
  8. 4.2.3 Global Metformin Drugs Sales Market Share by Type (2021-2032)
  9. 4.3 Global Metformin Drugs Revenue by Type
  10. 4.3.1 Global Metformin Drugs Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Metformin Drugs Revenue by Type (2021-2032)
  12. 4.3.3 Global Metformin Drugs Revenue Market Share by Type (2021-2032)
5 Metformin Drugs Market by Application
  1. 5.1 Metformin Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Stores
  4. 5.2 Global Metformin Drugs Sales by Application
  5. 5.2.1 Global Metformin Drugs Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Metformin Drugs Sales by Application (2021-2032)
  7. 5.2.3 Global Metformin Drugs Sales Market Share by Application (2021-2032)
  8. 5.3 Global Metformin Drugs Revenue by Application
  9. 5.3.1 Global Metformin Drugs Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Metformin Drugs Revenue by Application (2021-2032)
  11. 5.3.3 Global Metformin Drugs Revenue Market Share by Application (2021-2032)
6 Global Metformin Drugs Sales by Region
  1. 6.1 Global Metformin Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Metformin Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Metformin Drugs Sales by Region (2021-2026)
  4. 6.2.2 Global Metformin Drugs Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Metformin Drugs Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Metformin Drugs Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Metformin Drugs Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Metformin Drugs Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Metformin Drugs Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Metformin Drugs Revenue by Region
  1. 7.1 Global Metformin Drugs Revenue by Region
  2. 7.1.1 Global Metformin Drugs Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Metformin Drugs Revenue by Region (2021-2026)
  4. 7.1.3 Global Metformin Drugs Revenue by Region (2027-2032)
  5. 7.1.4 Global Metformin Drugs Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Metformin Drugs Revenue (2021-2032)
  8. 7.2.2 North America Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Metformin Drugs Revenue (2021-2032)
  11. 7.3.2 Europe Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Metformin Drugs Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Metformin Drugs Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Metformin Drugs Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Alkem
  2. 8.1.1 Alkem Company Information
  3. 8.1.2 Alkem Business Overview
  4. 8.1.3 Alkem Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Alkem Metformin Drugs Product Portfolio
  6. 8.1.5 Alkem Recent Developments
  7. 8.2 Apotex
  8. 8.2.1 Apotex Company Information
  9. 8.2.2 Apotex Business Overview
  10. 8.2.3 Apotex Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Apotex Metformin Drugs Product Portfolio
  12. 8.2.5 Apotex Recent Developments
  13. 8.3 Atlas Pharmaceuticals
  14. 8.3.1 Atlas Pharmaceuticals Company Information
  15. 8.3.2 Atlas Pharmaceuticals Business Overview
  16. 8.3.3 Atlas Pharmaceuticals Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Atlas Pharmaceuticals Metformin Drugs Product Portfolio
  18. 8.3.5 Atlas Pharmaceuticals Recent Developments
  19. 8.4 Bristol-Myers Squibb
  20. 8.4.1 Bristol-Myers Squibb Company Information
  21. 8.4.2 Bristol-Myers Squibb Business Overview
  22. 8.4.3 Bristol-Myers Squibb Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Bristol-Myers Squibb Metformin Drugs Product Portfolio
  24. 8.4.5 Bristol-Myers Squibb Recent Developments
  25. 8.5 Dr. Reddy’s Laboratories
  26. 8.5.1 Dr. Reddy’s Laboratories Company Information
  27. 8.5.2 Dr. Reddy’s Laboratories Business Overview
  28. 8.5.3 Dr. Reddy’s Laboratories Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Dr. Reddy’s Laboratories Metformin Drugs Product Portfolio
  30. 8.5.5 Dr. Reddy’s Laboratories Recent Developments
  31. 8.6 Mallinckrodt
  32. 8.6.1 Mallinckrodt Company Information
  33. 8.6.2 Mallinckrodt Business Overview
  34. 8.6.3 Mallinckrodt Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Mallinckrodt Metformin Drugs Product Portfolio
  36. 8.6.5 Mallinckrodt Recent Developments
  37. 8.7 Teva Pharmaceuticals
  38. 8.7.1 Teva Pharmaceuticals Company Information
  39. 8.7.2 Teva Pharmaceuticals Business Overview
  40. 8.7.3 Teva Pharmaceuticals Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Teva Pharmaceuticals Metformin Drugs Product Portfolio
  42. 8.7.5 Teva Pharmaceuticals Recent Developments
  43. 8.8 Torrent Pharmaceuticals
  44. 8.8.1 Torrent Pharmaceuticals Company Information
  45. 8.8.2 Torrent Pharmaceuticals Business Overview
  46. 8.8.3 Torrent Pharmaceuticals Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Torrent Pharmaceuticals Metformin Drugs Product Portfolio
  48. 8.8.5 Torrent Pharmaceuticals Recent Developments
  49. 8.9 Viatris
  50. 8.9.1 Viatris Company Information
  51. 8.9.2 Viatris Business Overview
  52. 8.9.3 Viatris Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Viatris Metformin Drugs Product Portfolio
  54. 8.9.5 Viatris Recent Developments
  55. 8.10 Novartis
  56. 8.10.1 Novartis Company Information
  57. 8.10.2 Novartis Business Overview
  58. 8.10.3 Novartis Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novartis Metformin Drugs Product Portfolio
  60. 8.10.5 Novartis Recent Developments
  61. 8.11 Sun Pharmaceutical Industries
  62. 8.11.1 Sun Pharmaceutical Industries Company Information
  63. 8.11.2 Sun Pharmaceutical Industries Business Overview
  64. 8.11.3 Sun Pharmaceutical Industries Metformin Drugs Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sun Pharmaceutical Industries Metformin Drugs Product Portfolio
  66. 8.11.5 Sun Pharmaceutical Industries Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Metformin Drugs Value Chain Analysis
  2. 9.1.1 Metformin Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Metformin Drugs Production Mode & Process
  6. 9.2 Metformin Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Metformin Drugs Distributors
  9. 9.2.3 Metformin Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst